DYSIS Medical Inc.  

24 Superior Drive
Suite 400
Natick,  MA 
United States
http://www.dysismedical.com

• Booth: 743

DYSIS® is computer-aided colposcopy with innovative cervical mapping that quantifies acetowhitening and creates the color-coded DYSISmap™ to help healthcare professionals detect cervical lesions more clearly. The IMPROVE-COLPO study demonstrated an increased detection of patients with high-grade lesions by 44% when the DYSISmap was used for biopsy selection after a thorough visual colposcopic assessment. Additionally, high-resolution images and video (including exam playback) improve documentation, patient communication and help healthcare professionals direct patients with greater assurance for screening, treatment or conservative management using SMARTtrack™, a side-by-side comparison of a patient’s DYSIS colposcopy exams. DYSIS is used by healthcare professionals globally.

 Press Releases

• DYSIS Announces New Out of the Box Ready, Compact Colposcope Design with Computer-Aided Cervical Mapping (Sep 10, 2021)

  DYSIS View is the newest colposcope that includes the DYSISmap™ and generates the data that can help healthcare professionals detect cervical lesions more clearly.

  July 15, 2021 — ATLANTA, Georgia — DYSIS Medical Inc. is excited to announce the launch of DYSIS® View, an out of the box ready, compact and portable colposcope, which includes the company’s innovative computer-aided cervical mapping technology that helps healthcare professionals detect cervical lesions more clearly.

  The DYSIS family of colposcopes include the novel DYSISmap, which is a color-coded summary of the acetowhitening effect of the patient’s cervix. Colors are allocated on the map depending on the acetowhitening changes measured by DYSIS during the examination. This data helps healthcare professionals improve biopsy selection.   In the IMPROVE-COLPO study, when map-assisted biopsies were added to colposcopy exams, detection of patients with CIN2+ increased by 44%1.

  “We are thrilled to bring DYSIS View to market to compliment our already strong presence with DYSIS Ultra.” said Darin Hammers, CEO of DYSIS Medical. “While DYSIS View is much more compact and portable than our previous colposcope designs, it’s equal in sophistication and technology. It fills a gap in the market where we’re able to provide our innovative mapping technology to a wide range of healthcare professionals.”

  In addition to the innovative cervical mapping technology, DYSIS View includes a camera for high resolution exam videos and images, instant replay of colposcopy exams, DYSIS SMARTtrack™ to compare a patient’s DYSIS View colposcopy exams and a patient database for record storage. Find out more about the new DYSIS View colposcope at dysismedical.com.

• DYSIS Announces Medicare Reimbursement Rates (Sep 10, 2021)

  DYSIS Announces Medicare Reimbursement Rates for the new Add-On CPT^® Code 57465, which can be used for DYSIS Smart Colposcopy, Effective January 2021

  DYSIS Smart Colposcopy is computer-aided cervical imaging that adds the DYSISmap to a standard colposcopic assessment with clinical studies showing that it helps clinicians increase detection of high-grade cervical lesions.

  December 3, 2020 — ALPHARETTA, Georgia — DYSIS Medical, Inc. announced today that the Centers for Medicare and Medicaid Services (CMS) issued their 2021 Medicare Physician Fee Schedule1 (PFS) that now includes reimbursement rates for Add-On CPT^® Code 57465 (computer-aided mapping of cervix uteri during colposcopy, including optical dynamic spectral imaging and algorithmic quantification of the acetowhitening effect) under which DYSIS Smart Colposcopy with DYSISmap™ is billed.  The payment rate for the new add-on code (57465) will provide for a national average Medicare reimbursement rate of $54.45 (Total Non-Facility RVU 1.68) in the office.

  “I have performed DYSIS colposcopy with the adjunctive DYSISmap on my patients for the past five years, and it has been a tremendous benefit,” said Karen Harris, MD.  Dr. Harris is an Ob-Gyn and Residency Program Director at Women’s Group of North Florida and is Past-District XII chairperson of ACOG. “The added reimbursement for Medicare patients shows the value of this added service, and we look forward to future private payors also reimbursing.”

  “The CMS decision to provide reimbursement for computer-aided mapping of the cervix is another important milestone for DYSIS as well as a step forward in the early detection of cervical pre-cancers,” said Darin Hammers, CEO of DYSIS Medical. “Medicare reimbursing physicians for computer-aided mapping of the cervix will help in our goal of increasing patient access to DYSIS cervical mapping technology.”

  The unique feature of the DYSIS Colposcope is that it accurately measures the acetowhitening of the cervical epithelium using a proprietary technology called Dynamic Spectral Imaging. The results are summarized in the DYSISmap that is overlaid on the live image of the cervix. The inclusion of the DYSISmap information with the standard colposcopic indications can assist with the identification of cervical disease.  In the IMPROVE-COLPO study, when map-assisted biopsies were added to colposcopy exams, detection of patients with CIN2+ increased by 44%2.

  Add-on code 57465 can be used in conjunction with primary procedure codes 57420, 57421, 57452, 57454, 57455, 57456, 57460, and 57461. DYSIS Medical will continue its efforts to ensure positive coverage decisions of both public and private payers.

  ¹https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeeSched
  ²DeNardis et al. Int J Womens Health. 2017; 9: 717–725.
  CPT^® is a registered trademark of the American Medical Association

 Products